Pablo F. Belaunzarán-Zamudio

Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico

Braulio A. Marfil‐Garza, Pablo F. Belaunzarán-Zamudio, Alfonso Gulı́as-Herrero et al. · PLoS ONE · 2018 · 101 citations · Full text

High prevalence of late diagnosis of HIV in Mexico during the HAART era

Brenda Crabtree‐Ramírez, Yanink Caro-Vega, Pablo F. Belaunzarán-Zamudio et al. · Salud Pública de México · 2012 · 81 citations · Full text

Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study

Casey Smiley, Peter F. Rebeiro, Carina César et al. · The Lancet HIV · 2021 · 70 citations · Full text

Sexual Health, Epidemiological Trend, Epidemiological Outcome +10

Prospective, Randomized, Open Label Trial of Efavirenz vs Lopinavir/Ritonavir in HIV+ Treatment-Naive Subjects With CD4+<200 cell/mm3 in Mexico

Juan Sierra‐Madero, Angelina Villası́s-Keever, Patricia Méndez et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 62 citations

Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome

Supriya Ravichandran, Megan Hahn, Pablo F. Belaunzarán-Zamudio et al. · Nature Communications · 2019 · 56 citations · Full text